Posterior cruciate ligament (PCL)

The posterior cruciate ligament (PCL) is a robust intra-articular structure located within the knee joint, extending from the posterior intercondylar area of the tibia to the lateral aspect of the medial femoral condyle (StatPearls, NBK430726). Its primary biological role is to serve as the fundamental stabilizer preventing posterior translation of the tibia relative to the femur, while also contributing to the stability of the knee against rotational forces (Mayo Clinic, PCL injury). As an anatomical tissue composed of dense regular connective tissue—primarily Type I collagen—the PCL does not function as a molecular receptor, enzyme, or transporter, and thus is not a target in the context of traditional drug discovery (Orthobullets, PCL Injury). Clinical issues involving the PCL typically involve traumatic ruptures or strains, often resulting from high-energy impacts such as "dashboard injuries" in motor vehicle accidents (StatPearls, NBK430726). Management of these conditions is predominantly mechanical or rehabilitative, involving surgical reconstruction or physical therapy, rather than direct pharmacological modulation of the ligament's molecular pathways (Mayo Clinic, PCL injury). While systemic medications like non-steroidal anti-inflammatory drugs (NSAIDs) may be used to manage pain and swelling associated with PCL injuries, they do not interact with the ligament as a specific molecular target (StatPearls, NBK430726). Consequently, the PCL is categorized as an anatomical component of the musculoskeletal system rather than a biochemical target for drug development (Orthobullets, PCL Injury).

Other names

PCLPosterior cruciate ligament of knee

Not applicable (Anatomical structure)